
Christopher J. Novosad
Examiner (ID: 10390, Phone: (571)272-6993 , Office: P/3671 )
| Most Active Art Unit | 3671 |
| Art Unit(s) | 3671, 3616, 3501, 3641, 2899 |
| Total Applications | 3135 |
| Issued Applications | 2776 |
| Pending Applications | 115 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 326636
[patent_doc_number] => 07514407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-07
[patent_title] => 'Spheron component peptides and pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 10/444070
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16957
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/514/07514407.pdf
[firstpage_image] =>[orig_patent_app_number] => 10444070
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/444070 | Spheron component peptides and pharmaceutical compositions | May 22, 2003 | Issued |
Array
(
[id] => 7426798
[patent_doc_number] => 20040229837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Treatment of neurodegenerative diseases'
[patent_app_type] => new
[patent_app_number] => 10/440345
[patent_app_country] => US
[patent_app_date] => 2003-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6557
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229837.pdf
[firstpage_image] =>[orig_patent_app_number] => 10440345
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/440345 | Treatment of neurodegenerative diseases | May 14, 2003 | Abandoned |
Array
(
[id] => 7341684
[patent_doc_number] => 20040191291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Composition and method for nerve regeneration'
[patent_app_type] => new
[patent_app_number] => 10/427741
[patent_app_country] => US
[patent_app_date] => 2003-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 100888
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20040191291.pdf
[firstpage_image] =>[orig_patent_app_number] => 10427741
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/427741 | Composition and method for nerve regeneration | Apr 29, 2003 | Abandoned |
Array
(
[id] => 6663664
[patent_doc_number] => 20030202990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Intracranial botulinum toxin therapy for focal epilepsy'
[patent_app_type] => new
[patent_app_number] => 10/421504
[patent_app_country] => US
[patent_app_date] => 2003-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 27269
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20030202990.pdf
[firstpage_image] =>[orig_patent_app_number] => 10421504
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/421504 | Intracranial botulinum toxin therapy for focal epilepsy | Apr 21, 2003 | Issued |
Array
(
[id] => 232623
[patent_doc_number] => 07598048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-06
[patent_title] => 'Screening methods for identifying agents that modulate output of a circadian pacemaker'
[patent_app_type] => utility
[patent_app_number] => 10/417426
[patent_app_country] => US
[patent_app_date] => 2003-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 26754
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/598/07598048.pdf
[firstpage_image] =>[orig_patent_app_number] => 10417426
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/417426 | Screening methods for identifying agents that modulate output of a circadian pacemaker | Apr 14, 2003 | Issued |
Array
(
[id] => 5738068
[patent_doc_number] => 20060008458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Prevention of brain inflammation as a result of induced autoimmune response'
[patent_app_type] => utility
[patent_app_number] => 10/510820
[patent_app_country] => US
[patent_app_date] => 2003-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1909
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20060008458.pdf
[firstpage_image] =>[orig_patent_app_number] => 10510820
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/510820 | Prevention of brain inflammation as a result of induced autoimmune response | Apr 13, 2003 | Abandoned |
Array
(
[id] => 5738068
[patent_doc_number] => 20060008458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Prevention of brain inflammation as a result of induced autoimmune response'
[patent_app_type] => utility
[patent_app_number] => 10/510820
[patent_app_country] => US
[patent_app_date] => 2003-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1909
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20060008458.pdf
[firstpage_image] =>[orig_patent_app_number] => 10510820
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/510820 | Prevention of brain inflammation as a result of induced autoimmune response | Apr 13, 2003 | Abandoned |
Array
(
[id] => 7445552
[patent_doc_number] => 20040009593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury'
[patent_app_type] => new
[patent_app_number] => 10/406817
[patent_app_country] => US
[patent_app_date] => 2003-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14475
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009593.pdf
[firstpage_image] =>[orig_patent_app_number] => 10406817
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/406817 | Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury | Apr 3, 2003 | Issued |
Array
(
[id] => 7201985
[patent_doc_number] => 20040086881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Novel human G-protein coupled receptor, BMSOTR, and splice variant thereof'
[patent_app_type] => new
[patent_app_number] => 10/334360
[patent_app_country] => US
[patent_app_date] => 2003-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 65573
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086881.pdf
[firstpage_image] =>[orig_patent_app_number] => 10334360
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/334360 | Novel human G-protein coupled receptor, BMSOTR, and splice variant thereof | Mar 11, 2003 | Abandoned |
Array
(
[id] => 6797016
[patent_doc_number] => 20030175890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'FAIL molecules and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/384850
[patent_app_country] => US
[patent_app_date] => 2003-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 48514
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175890.pdf
[firstpage_image] =>[orig_patent_app_number] => 10384850
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/384850 | FAIL molecules and uses thereof | Mar 9, 2003 | Issued |
Array
(
[id] => 7436122
[patent_doc_number] => 20040002460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Spheron components useful in determining compounds capable of treating symptoms of Alzheimer\'s disease, and treatments and animal models produced therefrom'
[patent_app_type] => new
[patent_app_number] => 10/378065
[patent_app_country] => US
[patent_app_date] => 2003-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16286
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002460.pdf
[firstpage_image] =>[orig_patent_app_number] => 10378065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/378065 | Spheron components useful in determining compounds capable of treating symptoms of Alzheimer's disease, and treatments and animal models produced therefrom | Mar 3, 2003 | Abandoned |
Array
(
[id] => 7354845
[patent_doc_number] => 20040048795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors'
[patent_app_type] => new
[patent_app_number] => 10/375696
[patent_app_country] => US
[patent_app_date] => 2003-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11395
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048795.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375696
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375696 | Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors | Feb 25, 2003 | Abandoned |
Array
(
[id] => 5609325
[patent_doc_number] => 20060270841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Assays to monitor amyloid precursor protein processing'
[patent_app_type] => utility
[patent_app_number] => 10/504446
[patent_app_country] => US
[patent_app_date] => 2003-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 76
[patent_figures_cnt] => 76
[patent_no_of_words] => 19930
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270841.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504446
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504446 | Assays to monitor amyloid precursor protein processing | Feb 24, 2003 | Abandoned |
Array
(
[id] => 4859115
[patent_doc_number] => 20080267965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Use of Bcma as an Immunoregulatory Agent'
[patent_app_type] => utility
[patent_app_number] => 10/505376
[patent_app_country] => US
[patent_app_date] => 2003-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11590
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20080267965.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505376
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505376 | Use of Bcma as an Immunoregulatory Agent | Feb 20, 2003 | Abandoned |
Array
(
[id] => 6912320
[patent_doc_number] => 20050176078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Detection and/or monitoring of synuclein-related diseases'
[patent_app_type] => utility
[patent_app_number] => 10/503416
[patent_app_country] => US
[patent_app_date] => 2003-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7987
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176078.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503416
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503416 | Detection and/or monitoring of synuclein-related diseases | Feb 13, 2003 | Abandoned |
Array
(
[id] => 6822119
[patent_doc_number] => 20030220280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate CNS nerve regeneration'
[patent_app_type] => new
[patent_app_number] => 10/359554
[patent_app_country] => US
[patent_app_date] => 2003-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5677
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220280.pdf
[firstpage_image] =>[orig_patent_app_number] => 10359554
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/359554 | Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate CNS nerve regeneration | Feb 6, 2003 | Abandoned |
Array
(
[id] => 7330648
[patent_doc_number] => 20040254348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Novel polypeptide and dna thereof'
[patent_app_type] => new
[patent_app_number] => 10/332738
[patent_app_country] => US
[patent_app_date] => 2003-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25937
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254348.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332738
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332738 | Novel polypeptide and dna thereof | Jan 9, 2003 | Abandoned |
Array
(
[id] => 6797468
[patent_doc_number] => 20030176342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Novel potassium channel'
[patent_app_type] => new
[patent_app_number] => 10/332175
[patent_app_country] => US
[patent_app_date] => 2003-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11232
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176342.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332175
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332175 | Novel potassium channel | Jan 6, 2003 | Abandoned |
Array
(
[id] => 6683283
[patent_doc_number] => 20030119147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Novel SLGP protein and nucleic acid molecules and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/336489
[patent_app_country] => US
[patent_app_date] => 2003-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 40801
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119147.pdf
[firstpage_image] =>[orig_patent_app_number] => 10336489
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/336489 | Novel SLGP protein and nucleic acid molecules and uses therefor | Jan 1, 2003 | Abandoned |
Array
(
[id] => 4570524
[patent_doc_number] => 07824670
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-02
[patent_title] => 'Use of il6r/il6 chimera in nerve cell regeneration'
[patent_app_type] => utility
[patent_app_number] => 10/498899
[patent_app_country] => US
[patent_app_date] => 2002-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11468
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/824/07824670.pdf
[firstpage_image] =>[orig_patent_app_number] => 10498899
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/498899 | Use of il6r/il6 chimera in nerve cell regeneration | Dec 30, 2002 | Issued |